Jazz Pharmaceuticals Announces FDA Acceptance and Priority Review of Supplemental NDA for Xywav™ Oral Solution
Jazz Pharmaceuticals plc today announced that the U.S. Food and Drug Administration (FDA) has granted Priority ...
Read moreJazz Pharmaceuticals plc today announced that the U.S. Food and Drug Administration (FDA) has granted Priority ...
Read moreJazz Pharmaceuticals plc announced that the U.S. Food and Drug Administration (FDA) approved a revised label ...
Read moreAddress: | Pharma Reg News, First floor, Shop no.1 , Plot no 241,242, Near Fire station, GIDC, Ankleshwar, Gujarat - 393002. |
Phone: | +91 8511586232, +91 9029066605 |
Email: | author@pharmaregnews.com |
© 2021 - Pharmaregnews.com. Developed by YESWEUS.
© 2021 - Pharmaregnews.com. Developed by YESWEUS.